Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sy

Showing results (311-320 of 341) with videos related to

Pageof 35
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2025
Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United StatesHung-Fu Tseng, Lina S Sy, Bradley K Ackerson, et al.
Open Forum Infectious Diseases|April 22, 2026
Comparison of Hospitalization Costs Associated With Human Metapneumovirus and Respiratory Syncytial Virus Infection in US AdultsBradley K Ackerson, Emily Rayens, Lina S Sy, et al.
Open Forum Infectious Diseases|July 7, 2018
Pneumococcal Conjugate Vaccine Safety in Elderly AdultsHung Fu Tseng, Lina S Sy, Lei Qian, et al.
Pharmacoepidemiology and Drug Safety|December 5, 2019
The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety DatalinkWei Yu, Chengyi Zheng, Fagen Xie, et al.
Nature Medicine|February 21, 2022
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variantsHung Fu Tseng, Bradley K Ackerson, Yi Luo, et al.
Vaccine|December 23, 2022
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccinationStanley Xu, Runxin Huang, Lina S Sy, et al.
Nature Medicine|April 22, 2022
Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variantsHung Fu Tseng, Bradley K Ackerson, Yi Luo, et al.
Vaccine|April 25, 2022
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemicStanley Xu, Vennis Hong, Lina S Sy, et al.
Annals of the Rheumatic Diseases|February 20, 2025
Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series studyEmily Rayens, Lina S Sy, Lei Qian, et al.
Journal of Clinical and Translational Science|March 7, 2025
Collaborating with and enabling diverse communities to address health inequities: The experiences of a community engagement and outreach teamReimund Serafica, Lorraine S Evangelista, Tony Ward, et al.
Pageof 35

Showing results (311-320 of 341) with videos related to

Sort By:
Pageof 35
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2025
Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United StatesHung-Fu Tseng, Lina S Sy, Bradley K Ackerson, et al.
Open Forum Infectious Diseases|April 22, 2026
Comparison of Hospitalization Costs Associated With Human Metapneumovirus and Respiratory Syncytial Virus Infection in US AdultsBradley K Ackerson, Emily Rayens, Lina S Sy, et al.
Open Forum Infectious Diseases|July 7, 2018
Pneumococcal Conjugate Vaccine Safety in Elderly AdultsHung Fu Tseng, Lina S Sy, Lei Qian, et al.
Pharmacoepidemiology and Drug Safety|December 5, 2019
The use of natural language processing to identify vaccine-related anaphylaxis at five health care systems in the Vaccine Safety DatalinkWei Yu, Chengyi Zheng, Fagen Xie, et al.
Nature Medicine|February 21, 2022
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variantsHung Fu Tseng, Bradley K Ackerson, Yi Luo, et al.
Vaccine|December 23, 2022
A safety study evaluating non-COVID-19 mortality risk following COVID-19 vaccinationStanley Xu, Runxin Huang, Lina S Sy, et al.
Nature Medicine|April 22, 2022
Author Correction: Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variantsHung Fu Tseng, Bradley K Ackerson, Yi Luo, et al.
Vaccine|April 25, 2022
Changes in incidence rates of outcomes of interest in vaccine safety studies during the COVID-19 pandemicStanley Xu, Vennis Hong, Lina S Sy, et al.
Annals of the Rheumatic Diseases|February 20, 2025
Effectiveness and safety of the recombinant zoster vaccine in individuals ≥50 years of age with rheumatoid arthritis: a matched cohort and self-controlled case series studyEmily Rayens, Lina S Sy, Lei Qian, et al.
Journal of Clinical and Translational Science|March 7, 2025
Collaborating with and enabling diverse communities to address health inequities: The experiences of a community engagement and outreach teamReimund Serafica, Lorraine S Evangelista, Tony Ward, et al.
Pageof 35